The DOI matches its Crossref record.
Design and characterization of chionodracine-derived antimicrobial peptides with enhanced activity against drug-resistant human pathogens
Abstract
Design of new chionodracine-derived peptides with potent activity against drug-resistant human pathogens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Fitting the changes in molar ellipticity resulted in a partition constant Kx of 1.1 ± 0.2 mM, suggesting a weak interaction of this polypeptide with the DMPC LUV [43–45].”
From Intrinsically disordered HAX-1 regulates Ca2+ cycling by interacting with lipid membranes and the phospholamban cytoplasmic region (2020) · cites this paper as [45]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 62
- Takahashi, 2017, Dermatol. Clin., 35, 39, 10.1016/j.det.2016.07.006 · DOI
- Boman, 2003, J. Intern. Med., 254, 197, 10.1046/j.1365-2796.2003.01228.x · DOI · Paper page
- Zheng, 2017, Antimicrob. Agents Chemother., 61, e00686-17, 10.1128/AAC.00686-17 · DOI
- Xie, 2017, Chem. Biol. Drug Des., 90, 690, 10.1111/cbdd.12988 · doi:10.1111/cbdd.12988
- de Paula, 2018, Molecules, 23, 2040, 10.3390/molecules23082040 · DOI
- Hale, 2007, Expert Rev. Anti-Infect. Ther., 5, 951, 10.1586/14787210.5.6.951 · DOI · Paper page
- Epand, 2010, Biophys. J., 98, 2564, 10.1016/j.bpj.2010.03.002 · DOI
- Porcelli, 2008, Biochemistry, 47, 5565, 10.1021/bi702036s · DOI · Paper page
- Porcelli, 2006, Biochemistry, 45, 5793, 10.1021/bi0601813 · DOI · Paper page
- Porcelli, 2013, Methods Mol. Biol., 1063, 159, 10.1007/978-1-62703-583-5_9 · DOI
- Deslouches, 2015, Antimicrob. Agents Chemother., 59, 1329, 10.1128/AAC.03937-14 · DOI
- Marcotte, 2003, Chem. Phys. Lipids, 122, 107, 10.1016/S0009-3084(02)00182-2 · DOI
- Epand, 2004, Biochemistry, 43, 9527, 10.1021/bi049414l · DOI
- Omidvar, 2016, Biochim. Biophys. Acta, 1864, 1739, 10.1016/j.bbapap.2016.08.017 · DOI
- White, 1998, Biochim. Biophys. Acta, 1376, 339, 10.1016/S0304-4157(98)00021-5 · DOI · Paper page
- Koehler, 2009, Proteins, 76, 13, 10.1002/prot.22315 · DOI
- Zelezetsky, 2006, Biochim. Biophys. Acta, 1758, 1436, 10.1016/j.bbamem.2006.03.021 · DOI · Paper page
- Wimley, 2010, ACS Chem. Biol., 5, 905, 10.1021/cb1001558 · DOI · Paper page
- Sani, 2016, Acc. Chem. Res., 49, 1130, 10.1021/acs.accounts.6b00074 · DOI · Paper page
- Brogden, 2005, Nat. Rev. Microbiol., 3, 238, 10.1038/nrmicro1098 · DOI · Paper page
- Noga, 2003, Drug News Perspect., 16, 87, 10.1358/dnp.2003.16.2.829325 · doi:10.1358/dnp.2003.16.2.829325
- Chekmenev, 2006, Biochim. Biophys. Acta, 1758, 1359, 10.1016/j.bbamem.2006.03.034 · DOI
- Lee, 2007, Biochemistry, 46, 3653, 10.1021/bi062233u · doi:10.1021/bi062233u
- Park, 2011, Biochemistry, 50, 3288, 10.1021/bi101395j · DOI
- Buonocore, 2012, Fish Shellfish Immunol., 33, 1183, 10.1016/j.fsi.2012.09.005 · DOI
- Olivieri, 2015, Biochim. Biophys. Acta, 1848, 1285, 10.1016/j.bbamem.2015.02.030 · DOI
- Rice, 2010, Infect. Control Hosp. Epidemiol., 31, S7, 10.1086/655995 · DOI · Paper page
- Domadia, 2010, J. Am. Chem. Soc., 132, 18417, 10.1021/ja1083255 · DOI
- Ladokhin, 2000, Anal. Biochem., 285, 235, 10.1006/abio.2000.4773 · doi:10.1006/abio.2000.4773
- Ladokhin, 2009, Methods Enzymol., 466, 19, 10.1016/S0076-6879(09)66002-X · DOI
- Wimley, 1993, Biochemistry, 32, 6307, 10.1021/bi00076a001 · DOI
- Belokoneva, 2003, Biochim. Biophys. Acta, 1617, 22, 10.1016/j.bbamem.2003.08.010 · DOI
- Filippi, 2008, EMBO J., 27, 2545, 10.1038/emboj.2008.180 · DOI
- Latini, 2011, Cell Cycle, 10, 3719, 10.4161/cc.10.21.17905 · DOI
- Cree, 1997, Toxicol. In Vitro, 11, 553, 10.1016/S0887-2333(97)00060-X · doi:10.1016/s0887-2333(97)00060-x
- CLSI document M07-A9 Vol. 32 No. 2 Replaces M07-A8 Vol. 29 No. 2 Wayne, PA: Clinical and Laboratory Standards Institute; 2012./CLSI. Performance Standards for Antimicrobial Susceptibility Testing. Vol. Twenty-fifth Informational Supplement. Wayne, PA: Clinical Laboratory Standards Institute, (2015):M100-S25
- Straniero, 2016, Eur. J. Med. Chem., 120, 227, 10.1016/j.ejmech.2016.03.068 · DOI
- P.Verma , in Antimicrobial Susceptibility Testing Protocols , ed. L. Steele-Moore , A. C. Goodwin and R. Schwalbe , CRC Press , 2007 , pp. 275–298 , 10.1201/9781420014495.ch12 · DOI
- Lagerback, 2016, J. Antimicrob. Chemother., 71, 2321, 10.1093/jac/dkw213 · doi:10.1093/jac/dkw213
- Palmieri, 2014, J. Nanopart. Res., 16, 2583, 10.1007/s11051-014-2583-z · DOI
- Yount, 2006, Biochim. Biophys. Acta, 1758, 1373, 10.1016/j.bbamem.2006.03.027 · DOI
- Gautier, 2008, Bioinformatics, 24, 2101, 10.1093/bioinformatics/btn392 · DOI · Paper page
- Dathe, 1997, FEBS Lett., 403, 208, 10.1016/S0014-5793(97)00055-0 · DOI · Paper page
- Wieprecht, 1997, FEBS Lett., 417, 135, 10.1016/S0014-5793(97)01266-0 · doi:10.1016/s0014-5793(97)01266-0
- Postma, 2016, RSC Adv., 6, 94840, 10.1039/C6RA17944D · DOI
- Chen, 2005, J. Biol. Chem., 280, 12316, 10.1074/jbc.M413406200 · DOI · Paper page
- Gasteiger, 2003, Nucleic Acids Res., 31, 3784, 10.1093/nar/gkg563 · DOI · Paper page
- Dathe, 2001, FEBS Lett., 501, 146, 10.1016/S0014-5793(01)02648-5 · DOI · Paper page
- Abou-Zied, 2015, RSC Adv., 5, 14214, 10.1039/C4RA15246H · doi:10.1039/c4ra15246h
- Harmouche, 2017, Biochemistry, 56, 4269, 10.1021/acs.biochem.7b00526 · DOI
- Whitmore, 2008, Biopolymers, 89, 392, 10.1002/bip.20853 · DOI · Paper page
- Sreerama, 2000, Anal. Biochem., 287, 252, 10.1006/abio.2000.4880 · DOI · Paper page
- Zhang, 2016, Sci. Rep., 6, 27394, 10.1038/srep27394 · DOI · Paper page
- Wu, 2014, Antimicrob. Agents Chemother., 58, 5342, 10.1128/AAC.02823-14 · DOI
- Levison, 2009, Infect. Dis. Clin. North Am., 23, 791, 10.1016/j.idc.2009.06.008 · DOI · Paper page
- Masso-Silva, 2014, Pharmaceuticals, 7, 265, 10.3390/ph7030265 · DOI · Paper page
- Roscia, 2013, Curr. Protein Pept. Sci., 14, 641, 10.2174/138920371408131227155308 · doi:10.2174/138920371408131227155308
- Moravej, 2018, Microb. Drug Resist., 24, 747, 10.1089/mdr.2017.0392 · DOI · Paper page
- Hirsch, 2018, J. Antimicrob. Chemother., 10.1093/jac/dky386 · DOI
- Hollmann, 2018, Front. Chem., 6, 204, 10.3389/fchem.2018.00204 · DOI · Paper page
- J.O'Neill , Tackling drug-resistant infections globally: Final report and recommendations Wellcome Trust , 2016
- Wieprecht, 1997, Biochemistry, 36, 6124, 10.1021/bi9619987 · DOI · Paper page
Cited by
Larsen, E. K., Weber, D. K., Wang, S., Gopinath, T., Blackwell, D. J., Dalton, M. P., Robia, S. L., Gao, J., & Veglia, G. (2020) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2019.183034 · Cited by 15
Self-citation
Metadata
- Authors
- Olivieri, C., Bugli, F., Menchinelli, G., Veglia, G., Buonocore, F., Scapigliati, G., Stocchi, V., Ceccacci, F., Papi, M., Sanguinetti, M., & Porcelli, F.
- Affiliations
- Department for Innovation in Biological, Agrofood and Forest Systems
- Microbiology Institute
- Department of Chemistry
- CNR – Institute of Chemical Methodologies
- Physics Institute
- Venue
- RSC Advances
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2018
- Volume
- 8
- Issue
- 72
- Pages
- 41331-41346
- ISSN
- 2046-2069
- Cited by
- 23
- References
- 0
- Language
- en
- Funders
- Ministero dell'Istruzione, dell'Università e della Ricerca
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Design and characterization of chionodracine-derived antimicrobial peptides with enhanced activity against drug-resistant human pathogens. https://app.cochat.ai/papers/10.1039/c8ra08065h
- The paper
- Olivieri, C., Bugli, F., Menchinelli, G., Veglia, G., Buonocore, F., Scapigliati, G., Stocchi, V., Ceccacci, F., Papi, M., Sanguinetti, M., & Porcelli, F. (2018). Design and characterization of chionodracine-derived antimicrobial peptides with enhanced activity against drug-resistant human pathogens. RSC Advances. https://doi.org/10.1039/c8ra08065h
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.